BOSTON SCIENTIFIC CORP (BSX)
Surgical & Medical Instruments & Apparatus
Latest Price
$46.73
TTM P/E
19.55
Normalized P/E
37.31
Div Yield
--
Book Value
17.42
P/B Ratio
2.68
Valuation metrics
adjust assumptions →EPS: $1.94
Book value / share: $17.37
Formula: √(22.5 × EPS × BVPS)
Graham Number
$27.54
41% downside
Norm. op. income: $1.6B (median of 7yr)
Tax rate: 19%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$2.77
94% downside
Base FCF: $1.8B (median of recent 5yr)
Growth: 21%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$62.84
+34% upside
EPS: $1.94
Target P/E: 37×
Formula: EPS × P/E
P/E Fair Value
$71.78
+54% upside
Institutional Ownership
83.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 131.82M | $8.27B | 8.88% | -4.17M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 96.41M | $6.05B | 6.49% | -- | 2026-03-31 |
| FMR LLC | 74.23M | $4.66B | 5.00% | -23.16M | 2026-03-31 |
| STATE STREET CORP | 67.99M | $4.27B | 4.58% | +2.14M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 33.29M | $2.08B | 2.24% | +902.0K | 2026-03-31 |
| PRIMECAP MANAGEMENT CO/CA/ | 32.53M | $2.04B | 2.19% | +1.43M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 29.80M | $1.87B | 2.01% | -- | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 24.43M | $1.53B | 1.65% | +13.18M | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 22.76M | $1.43B | 1.53% | -2.36M | 2026-03-31 |
| MORGAN STANLEY | 22.27M | $1.40B | 1.50% | -693.9K | 2026-03-31 |